GlassScriptPhysician profile
Shiwani Singh
NPI 1346680311
$543.67
in general payments reported to CMS, 2019-2025
9 companies · $169 in 2025
The $169 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.92 · 2020: $60.44 · 2022: $37.38 · 2023: $193 · 2024: $67.94 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $429.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $135.41 | 2020-2025 | Shingrix |
| Abbvie INC. | $121.26 | 2023 | Mavyret |
| Exact Sciences Corporation | $120.84 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Medtronic, INC. | $64.68 | 2022-2025 | Closurefast, Intellis Adaptivestim |
| Tandem Diabetes Care, INC. | $27.87 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Pfizer INC. | $27.01 | 2023 | |
| Sanofi-Aventis U.S. LLC | $18.14 | 2022 | |
| Corcept Therapeutics | $15.92 | 2019 | |
| Novo Nordisk INC | $12.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shiwani Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.